# Pfizer Inc. (PFE) — Q4-2017 Earnings Results

**Report date:** 2018-01-30 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q4-2017

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 3.13%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | +6.19% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed a cautious optimism about future growth driven by R&D investments. They emphasized the need to strengthen their product pipeline.

**Key quotes:**

> Management highlighted ongoing investments in R&D as a priority.

> They noted the importance of maintaining strong product pipelines.

> There was a focus on future opportunities in emerging markets.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 3.13%, likely due to the lack of revenue details and guidance, which may have raised concerns among investors about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q4-2017_